BEIJING, Nov. 7, 2011 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical products
in China, today announced that it
will release financial results for the third quarter of fiscal 2011
ended September 30, 2011 on
Monday, November 14, 2011 before the
start of trading in the United
States.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
Company management will host a conference call for investors on
Monday, November 14, 2011 at
7:30 a.m. EST. Interested parties may
access the call by dialing (8610) 5137-7322 internationally, and
entering account No.: 16833078#, passcode: 999999# approximately 10
minutes prior to the scheduled start time.
For those unable to participate, the call will be available as a
live, listen-only webcast on the Company's website at
http://www.chinadhr.com. Following the live broadcast, an archive
will be available for one year.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products in China, including respiratory and oxygen
homecare medical products. The company develops and assembles its
own branded medical devices and homecare medical products from
third-party components. The company also distributes products
designed and manufactured by other companies, including medical
devices from IMD (Italy), Welch
Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and
JMS (Japan). Dehaier's technology
is based on five patents and five software copyrights;
additionally, we have three pending patents and six pending
software copyrights, and proprietary technology. More information
may be found at http://www.chinadhr.com.
Forward-looking Statements
This news release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, and other risks contained in reports filed by the
company with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether
made by or on behalf of the company, are expressly qualified by the
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. In addition, the company
disclaims any obligation to update any forward-looking statements
to reflect events or circumstances after the date hereof.
SOURCE Dehaier Medical Systems Ltd.